[Therapy of sleep disorders in old age].
D000367:Age Factors; D002090:Butyrophenones / Q000627:therapeutic use; D002110:Caffeine / Q000627:therapeutic use; D002301:Cardiac Glycosides / Q000627:therapeutic use; D002561:Cerebrovascular Disorders / Q000150:complications; D002719:Chlormethiazole / Q000627:therapeutic use; D003704:Dementia / Q000150:complications; D003911:Dextrans / Q000627:therapeutic use; D004878:Ergotamine / Q000627:therapeutic use; D005860:Germany, West; D006333:Heart Failure / Q000175:diagnosis; D006801:Humans; D006993:Hypnotics and Sedatives / Q000627:therapeutic use; D002504:Meclofenoxate / Q000627:therapeutic use; D009539:Nicotinic Acids / Q000627:therapeutic use; D010146:Pain; D026741:Physical Therapy Modalities; D011613:Psychotherapy; D012893:Sleep Wake Disorders / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology / Q000628:therapy*; D014149:Tranquilizing Agents / Q000627:therapeutic use
D002090:Butyrophenones; D002301:Cardiac Glycosides; D003911:Dextrans; D006993:Hypnotics and Sedatives; D009539:Nicotinic Acids; D014149:Tranquilizing Agents; D002719:Chlormethiazole; D002110:Caffeine; D002504:Meclofenoxate; D004878:Ergotamine
Behandlung von Schlafstörungen im Alter.